Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Motor Activity × Ipilimumab × Clear all

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 27 Carcinoma, Renal Cell 16 Carcinoma, Non-Small-Cell Lung 13 Carcinoma, Hepatocellular 7 Skin Neoplasms 6 Brain Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Glioblastoma 3 Carcinoma, Transitional Cell 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Mycosis Fungoides 2 Mesothelioma, Malignant 2 Mesothelioma 2 Lymphoma, T-Cell 2

Interventions

Exercise 28 Nutritional Status 4 Standard of Care 3 Preoperative Exercise 3 Control Groups 3 lime 2 Resistance Training 2 High-Intensity Interval Training 2 Fitness Trackers 2 Diet Therapy 2 tislelizumab 1 pembrolizumab 1 oncomodulin 1 diacetamate 1 blueberry extract 1 beta-Glucans 1 Whey Proteins 1 Wearable Electronic Devices 1 Walking 1 Vitamin D 1 Telemedicine 1 Tea 1 Tablets 1 TEMPO 1 Spermine Synthase 1 Roflumilast 1 Rehabilitation 1 Probiotics 1 Physical Therapy Modalities 1 Physical Examination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡